Abstract

RIVERA-ORDONEZ, ANDRÉS CAMILO et al. Guillain-Barré syndrome in a COVID-19 patient. Acta Med Colomb [online]. 2022, vol.47, n.2, pp.29-31.  Epub Jan 06, 2023. ISSN 0120-2448.  https://doi.org/10.36104/amc.2022.2204.

Coronavirus type 2 is a P-coronavirus whose infection is characterized by a predominantly respiratory clinical picture. However, neurological symptoms are garnering great interest related to pulmonary infection and direct viral invasion of the central nervous system, with a possible association between Guillain-Barré syndrome and SARS-CoV-2 infection. This report describes this relationship in a 44-year-old female patient with classical Guillain-Barré syndrome signs and symptoms on admission, and respiratory signs and symptoms six days prior to the onset of neurological symptoms. There were positive SARS-CoV IgG and IgM blood tests and an epidemiological link of direct contact with people infected with SARS-CoV-2. She required ICU care due to the risk of respiratory failure, along with immunoglobulin treatment, but did not need mechanical ventilation; she improved and was discharged. One month later she consulted again and was thought to have had a Guillain-Barré relapse. She was hospitalized and treated until she progressed and her symptoms resolved. (Acta Med Colomb 2022; 47. DOI:https://doi.org/10.36104/amc.2022.2204).

Keywords : SARS-CoV-2; COVID-19; Guillain-Barré; neuropathies; demyelinating diseases.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )